AV Fistula
10
2
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
10.0%
1 terminated out of 10 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
67%
4 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery
SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications
Ellipsys Vascular Access System Post Market Surveillance (PS) Study
Tissue Markers Predictive of Early Stenosis in the Arterovenous Fistula for Hemodialysis
The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation
Alucent Vessel Restoration System for AVF
av Fistula Patency Loss as a Cause of Fistula Failure and Hyperphosphatemia
Percutaneous Less Invasive AV Fistula for Vascular Access in ESRD
Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access
Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae